The World Health Organization (WHO), the United Nations Children��s Fund (UNICEF) and many other organizations are involved in the procurement of pharmaceutical products. In particular, the supply of pharmaceutical products used in the treatment of human immunodeficiency virus/acquired immunodeficie...
The recently unveiled African Union’s Bio-manufacturing Workforce Development Workshop Report 2023 and the United Nations Economic Development in Africa Report 2023 spotlight the critical role of a skilled and adaptable workforce. Additionally, the commitment of BRICS member states, Africa CDC, and...
A standard operating procedure (SOP) is a set of systematic instructions compiled by an organization to help workers carry out complex routine operations. SOPs aim to achieve efficiency, quality output and uniformity of performance, while reducing miscommunication and failure to comply with regulati...
National quantification of EMHLS is an annual exercise conducted by NMS under the direct supervision of MoH, and the exercise is intended to provide all public sector players/stakeholder in the health sector with feedback about facility needs in accordance with the NMS Act Cap 207 that states in par...
The NMS Act Cap 207 states that the corporation shall advise the Ministry of Health, Ministry of Finance, Planning and Economic Development, Ministry of Local Government and National Drug Authority on essential issues relating to the state of the Corporation and its future development as well as to...
The WHO Expert Committee on Specifications for Pharmaceutical Preparations met in Geneva from 14 to 18 October 2013. Dr M.-P. Kieny, Assistant Director- General of Health Systems and Innovation at the World Health Organization (WHO), welcomed participants on behalf of the Director-General. Dr Kieny...
A drug and therapeutics committee (DTC) provides such a forum, allowing all the relevant people to work together to improve health care delivery, whether in hospitals or other health facilities. In many developed countries a well functioning DTC has been shown to be very effective in addressing drug...
The purpose of this report is to inform the Ministry of Health and all stakeholders of the stock levels in the country as a tool that enables appropriate logistics decision making . This report highlights stock status, real challenges, bottlenecks but also recommends potential solutions to mitigate...
The WHA 54.11 WHO medicines strategy acknowledged the four main objectives of WHO��s medicines strategy, namely, to frame and implement policy; to ensure access; to ensure quality, safety and efficacy; and to promote rational use of medicines. The WHO medicines strategy 2004-2007 presents the strate...
The thirty-eighth meeting of the World Health Organization (WHO) Expert Committee on Drug Dependence (ECDD) took place in Geneva, Switzerland from 14 to 18 November 2016. Dr Suzanne Hill, Director, WHO Department of Essential Medicines and Health Products (EMP), opened the meeting. She welcomed all...
About 275 million people worldwide, which is roughly 5.6 per cent of the global population aged 15-64 years, used drugs at least once during 2016. Some 31 million of people who use drugs suffer from drug use disorders, meaning that their drug use is harmful to the point where they may need treatment...
The Ministry of Health (MoH) Department of Pharmaceuticals and Natural Medicines (DPNM) coordinated the first integrated quantification process for Essential Medicines and Health Supplies (EMHS) for the public and PNFP sector for Financial Years 2023/24 - 2025/26.�Quantification is a core component...
The organizations and agencies of the United Nations system and international and nongovernmental organizations are called upon to respond to an increasing number of largescale emergencies and disasters, many of which pose a serious threat to health. Much of the assistance provided in such situation...
